Collaboration Agreements (499)
Collaboration agreements include contracts that define joint initiatives between a company and other parties.
Browse by Industry
- Auto Components (1)
- Biotechnology (309)
- Communications Equipment (1)
- Consumer Finance (4)
- Diversified Consumer Services (1)
- Electrical Equipment (1)
- Health Care Equipment & Supplies (7)
- Health Care Technology (2)
- Life Sciences Tools & Services (5)
- Metals & Mining (1)
- Pharmaceuticals (37)
- Specialty Retail (1)
- Unassigned Industry (129)
- Collaboration, Option and License Agreement, dated August 23, 2021, by and between iBio, Inc. and RubrYc Therapeutics, Inc (iBio, Inc., Filed With SEC on August 27, 2021)
- Collaboration and License Agreement, dated August 23, 2021, by and between iBio, Inc. and RubrYc Therapeutics, Inc (iBio, Inc., Filed With SEC on August 27, 2021)
- Amended and Restated License and Collaboration Agreement, by and between the Registrant and Aventis Inc., dated as of December 17, 2015, as amended and restated as of August 16,... (DiCE MOLECULES HOLDINGS, LLC, Filed With SEC on August 25, 2021)
- Research and Development Collaboration and License Agreement, dated November 30, 2018, between TRIGR Therapeutics, Inc. and ABL Bio Inc (Olivia Ventures, Inc., Filed With SEC on August 16, 2021)
- Amendment No. 1 to Collaboration and License Agreement, effective as of April 8, 2021, by and between the Company and Commave Therapeutics SA (KEMPHARM, INC, Filed With SEC on August 13, 2021)
- Pilot Collaboration and Option Agreement, dated June 16, 2021, among Synlogic Operating Company, Inc. and Hoffman-La Roche Inc (SYNLOGIC, INC., Filed With SEC on August 12, 2021)
- Research Collaboration Agreement, dated May 5, 2021, by and between Nkarta, Inc. and CRISPR Therapeutics AG (Nkarta, Inc., Filed With SEC on August 12, 2021)
- Strategic Collaboration Agreement, dated February 21, 2020, by and between salesforce.com and ServiceMax, Inc (Pathfinder Acquisition Corp, Filed With SEC on August 12, 2021)
- License and Collaboration Agreement by and among the Company and Ji Xing Pharmaceuticals, Limited, dated May 15, 2021 (Milestone Pharmaceuticals Inc., Filed With SEC on August 11, 2021)
- Amendment to the Collaboration and License Agreement dated April 11, 2019, as amended, between Nanomerics Ltd. and Virpax Pharmaceuticals, Inc., dated April 6, 2021 (Virpax Pharmaceuticals, Inc., Filed With SEC on August 10, 2021)
